scispace - formally typeset
E

Emiko Urano

Researcher at National Institutes of Health

Publications -  38
Citations -  749

Emiko Urano is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Virus & Gene. The author has an hindex of 17, co-authored 36 publications receiving 665 citations. Previous affiliations of Emiko Urano include Kitasato University.

Papers
More filters
Journal ArticleDOI

Ligand-independent higher-order multimerization of CXCR4, a G-protein-coupled chemokine receptor involved in targeted metastasis

TL;DR: It is hypothesized that CXCR4 distributes to the cell surface as a multimer, in order to effectively sense, with increased avidity, the chemotaxis‐inducing ligand in the microenvironment, and this is the first report providing direct experimental evidence for the higher‐order multimerization of CX CR4 in vivo.
Journal ArticleDOI

Cell-permeable stapled peptides based on HIV-1 integrase inhibitors derived from HIV-1 gene products.

TL;DR: Stapled peptides, a new class of stabilized α-helical peptidomimetics were adopted to enhance the cell permeability of the above lead peptides and led to a remarkable increase in their potency in cells and a significant reduction of their cytotoxicity.
Journal ArticleDOI

Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors

TL;DR: Alkyl amine derivatives modified at the C-28 position of the BVM scaffold are identified that are markedly more potent than BVM against an HIV-1 clade B clone and show robust antiviral activity against a variant of NL4-3 containing the V7A polymorphism in SP1.
Journal ArticleDOI

Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma.

TL;DR: High‐throughput cytokine profiling might be a valuable tool for the differential diagnosis ofEBV‐associated B cell lymphomas and might deepen the understanding of the pathogenesis of EBV‐ associated B cell malignancies.